Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 10, Number 9—September 2004
Research

Methicillin-resistant Staphylococcus aureus in Europe, 1999–2002

Edine W. Tiemersma*Comments to Author , Stef L.A.M. Bronzwaer†, Outi Lyytikäinen†, John E. Degener‡, Paul Schrijnemakers*, Nienke Bruinsma*, Jos Monen*, Wolfgang Witte§, Hajo Grundmann*, and European Antimicrobial Resistance Surveillance System Participants
Author affiliations: *National Institute for Public Health and the Environment, Bilthoven, the Netherlands; †National Public Health Institute, Helsinki, Finland; ‡University Hospital Groningen, Groningen, the Netherlands; §Robert Koch Institute, Werningerode, Germany

Main Article

Figure 3

A) Variation in methicillin-resistant Staphylococcus aureus (MRSA) proportions between hospitals with AST results of >20 blood isolates, displayed by ranking of MRSA proportion (from lowest to highest). Only countries with more than one hospital are displayed. Hospital-specific proportions (open diamonds) are grouped per country. The solid horizontal bars represent the mean MRSA proportion per country. B) Local variation, showing the power-transformed variance being independent of the mean MR

Figure 3. A) Variation in methicillin-resistant Staphylococcus aureus (MRSA) proportions between hospitals with AST results of >20 blood isolates, displayed by ranking of MRSA proportion (from lowest to highest). Only countries with more than one hospital are displayed. Hospital-specific proportions (open diamonds) are grouped per country. The solid horizontal bars represent the mean MRSA proportion per country. B) Local variation, showing the power-transformed variance being independent of the mean MRSA proportion per country, displayed by ranking of MRSA proportion (from lowest to highest). Only hospitals reporting >20 isolates are included. Countries with less than five reporting hospitals are not shown (Iceland and Malta [1], Estonia [3], Bulgaria and Luxembourg [4]).

Main Article

1European Antimicrobial Resistance Surveillance System national representatives, 2002: Austria: H. Mittermayer, W. Koller; Belgium: H. Goossens, E. Hendrickx; Bulgaria: B. Markova; Croatia: S. Kalenic, A. Tambic-Andrasavic; Czech Republic: P. Urbaskova; Denmark: D. Monnet; Estonia: P. Naaber; Finland: O. Lyytikäinen, A. Nissinen; France: H. Aubry-Damon, P. Courvalin; Germany: U. Buchholz, W. Witte; Greece: N. Legakis, G. Vatopoulos; Hungary: M. Füzi; Ireland: D. O’Flanagan, O. Murphy; Iceland: K. Kristinsson; Israel: R. Raz; Italy: G. Cornaglia, P. D’Ancona; Luxembourg: R. Hemmer; Malta: M. Borg; Netherlands: A. de Neeling, E. Tiemersma; Norway: A. Hoiby, E. Bjørløw; Poland: W. Hryniewicz; Portugal: M. Caniça; Romania: I. Codita; Slovenia: M. Gubina, J. Kolman; Slovakia: L. Langsadl; Spain: F. Baquero, J. Campos; Sweden: B. Liljequist; United Kingdom: A. Johnson, M. Whale.

Page created: March 29, 2011
Page updated: March 29, 2011
Page reviewed: March 29, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external